AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haldorson, A. M.
Right arrow Articles by Opitz, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haldorson, A. M.
Right arrow Articles by Opitz, J. L.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1978 September; 14(3): 368-370
Copyright © 1978 American Society for Microbiology. All Rights Reserved.

Nonvalue of Neomycin Instillation after Intermittent Urinary Catheterization

Alice M. Haldorson1, Thomas F. Keys2, Myron D. Maker2 and Joachim L. Opitz3

1 Saint Mary's Hospital, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901
2 Division of Infectious Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901
3 Department of Physical Medicine and Rehabilitation, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901

ABSTRACT

This study evaluated weekly urine cultures of patients with neurogenic bladder disease who underwent intermittent urinary catheterization for bladder retraining. One group of 53 patients in 1974 received regular instillations of 0.1% neomycin after each catheterization. A similar group of 55 patients in 1975 did not receive neomycin and constituted a control group. Distribution of age, sex, diagnosis, and duration of bladder retraining was comparable in both groups. Quantitative bacterial colony counts of 104 to 105 or greater per ml of urine were considered significant. There was no difference in the incidence of bacteriuria between the neomycin-treated group and the control group (53 versus 49%, respectively), and most patients in each group had colony counts >105/ml. Escherichia coli was seen less frequently in neomycin-treated patients (43.4 versus 62.5%), but a greater percentage of infections due to Pseudomonas aeruginosa, group D streptococci, and yeasts was noted in the neomycin-treated group than in the control group (41.5 versus 22.5%).

Antimicrob Agents Chemother. 1978 September; 14(3): 368-370
Copyright © 1978 American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1978 by the American Society for Microbiology. All rights reserved.